Association of angiotensin-converting enzyme and endothelial Nitric Oxide synthase gene polymorphisms with vascular disease in ESRD patients in a Chinese population

Molecular and Cellular Biochemistry

Volumn 319, Issue 1-2, 2008, Pages 33-39

  Tang, Feng Ying ^a   Liu, Fu You ^a   Xie, Xiong Wei ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Angiotensin converting enzyme; Endothelial Nitric Oxide synthase; Gene polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GENOMIC DNA;

ADULT; ARTICLE; CEREBROVASCULAR DISEASE; CHINESE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; MUTATIONAL ANALYSIS; PATHOGENESIS; PERIPHERAL VASCULAR DISEASE; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; VASCULAR DISEASE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DNA MUTATIONAL ANALYSIS; FEMALE; GENOTYPE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MUTATION; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS; VASCULAR DISEASES;

EID: 55649087572     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-008-9874-6     Document Type: Article

References (39)

1. Lindner A, Charra B, Sherrard DJ et al (1974) Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290:697-701
2. Rostand SG, Brunzell JD, Cannon RO III et al (1991) Cardiovascular complications in renal failure. J Am Soc Nephrol 2:1053-1062
3. Zoccali C, Mallamaci F, Tripepi G (2004) Novel cardiovascular risk factors in end-stage renal disease. J Am Soc Nephrol 15(Suppl 1):S77-S80. doi: 10.1097/01.ASN.0000093240.84097.FE
4. Kimura H, Gejyo F, Yamaguchi T et al (1999) A cholesteryl ester transfer protein gene mutation and vascular disease in dialysis patients. J Am Soc Nephrol 10:294-299
5. Cambien F, Poirier O, Lecerf L et al (1992) Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644. doi: 10.1038/359641a0
6. Samani NJ, Thompson JR, O'Toole L et al (1996) A meta-analysis of the association of the deletion allele of the angiotensin converting enzyme gene with myocardial. infarction. Circulation 94:708-712
7. Staessen JA, Wang JG, Ginocchio G et al (1997) The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 15:1579-1592. doi: 10.1097/ 00004872-199715120-00059
8. Harden PN, Geddes C, Rowe PA et al (1995) Polymorphism in angiotensin-converting enzyme gene and progression of IgA nephropathy. Lancet 345:540-1542. doi: 10.1016/S0140-6736(95)91088-3
9. Hunley TE, Julian BA, Phillips JA et al (1996) Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 49:571-577. doi: 10.1038/ ki.1996.81
10. McLaughlin KJ, Harden PN, Ueda S et al (1996) The role of genetic polymorphisms of angiotensin converting enzyme in the progression of renal diseases. Hypertension 28:912-915
11. Hadjadj S, Belloum R, Bouhanick B et al (2001) Prognostic value of angiotensin I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus. J Am Soc Nephrol 12:541-549
12. Yildiz A, Akkaya V, Hatemi AC et al (2000) No association between deletion-type angiotensin-converting enzyme gene polymorphism and left-ventricular hypertrophy in hemodialysis patients. Nephron 84:130-135. doi: 10.1159/000045560
13. Landmesser U, Hornig B, Drexler H (2004) Endothelial function-a critical determinant in atherosclerosis? Circulation 109(Suppl II):II27-II33. doi: 10.1161/01.CIR.0000129501.88485.1f
14. Paradossi U, Ciofini E, Clerico A et al (2004) Endothelial function and carotid intimamedia thickness in young healthy subjects among endothelial nitric oxide synthase Glu298Asp and T-786C polymorphisms. Stroke 35:1305-1309. doi: 10.1161/01.STR.0000126482.86708.37
15. Naber CK, Baumgart D, Altmann C et al (2001) eNOS 894T allele and coronary blood flow at rest and during adenosine-induced hyperemia. Am J Physiol Heart Circ Physiol 281:1908-1912
16. Rossi GP, Taddei S, Virdis A et al (2004) The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients. J Am Coll Cardiol 41:938-945. doi: 10.1016/S0735-1097(02)03011-5
17. Casas JP, Bautista LE, Humphries SE et al (2004) Endothelial nitric oxide synthase genotype and ischemic heart disease. Circulation 109:1359-1365. doi: 10.1161/01.CIR.0000121357.76910.A3
18. Miyamoto Y, Saito Y, Kajiyama N et al (1998) Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32:3-8
19. Lembo G, De LN, Battagli C et al (2001) A common variant of endothelial nitric oxide synthase (Glu298Asp) is an independent risk factor for carotid atherosclerosis. Stroke 32:735-740
20. Nagase S, Suzuki H, Wang Y et al (2003) Association of eNOS gene polymorphisms with end stage renal diseases. Mol Cell Biochem 244:113-118. doi: 10.1023/A:1022473405275
21. Nishimura H, Tsuji H, Masuda H et al (1999) The effects of angiotensin metabolites on the regulation of coagulation and fibrinolysis in cultured rat aortic endothelial cells. Thromb Haemost 82:1516-1521
22. Boulanger CM, Caputo L, Levy BI (1995) Endothelial AT 1 -mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery. Hypertension 26:752-757
23. Ikeda U, Maeda Y, Kawahara Y et al (1995) Angiotensin II augments cytokine-stimulated nitric oxide synthesis in rat cardiac myocytes. Circulation 92:2683-2689
24. Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012. doi: 10.1056/NEJM199312303292706
25. Berdeli A, Sekuri C, Cam FS et al (2005) Association between the eNOS(Glu298ASP) and the RAS genes polymorphisms and premature coronary artery disease in a Turkish population. Clin Chim Acta 351:87-94. doi: 10.1016/j.cccn.2004.08.015
26. Ruggenenti P, Perna A, Zoccali C et al (2000) Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: Differences between women and men in relation to the ACE gene polymorphism. J Am Soc Nephrol 11:88-96
27. Page A, Reich H, Zhou J et al (2005) Endothelial nitric oxide synthase gene/gender interactions and the renal hemodynamic response to angiotensin II. J Am Soc Nephrol 16:3053-3060. doi: 10.1681/ ASN.2004110905
28. Cambien F, Poirier O, Lecerf L et al (1992) Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644. doi: 10.1038/359641a0
29. Rigat B, Hubert C, Alhene-Gelas F et al (1990) An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounts for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346. doi: 10.1172/JCI114844
30. Osono E, Kurihara S, Hayama N et al (1998) Insertion/deletion polymorphism in intron 16 of the ACE gene and left ventricular hypertrophy in patients with end-stage renal disease. Am J Kidney Dis 32:725-730. doi: 10.1016/S0272-6386(98)70126-X
31. Tseng CH, Tseng CP, Chong CK et al (2007) Angiotensin-converting enzyme gene polymorphism and stroke in type 2 diabetic patients in Taiwan. Eur J Clin Invest 37:483-491. doi: 10.1111/j.1365-2362.2007.01813.x
32. Tseng CH, Tseng CP (2002) Lack of association between angiotensin-converting enzyme gene polymorphism and peripheral vascular disease in type 2 diabetic patients in Taiwan. Circ J 66:1014-1018. doi: 10.1253/circj.66.1014
33. Wang XI, Sim AS, Wang MX et al (2000) Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett 471:45-50. doi: 10.1016/ S0014-5793(00)01356-9
34. Persu A, Stoenoiu MS, Messiaen T et al (2002) Modifier effect of eNOS in autosomal dominant polycystic kidney disease. Hum Mol Genet 11:229-241. doi: 10.1093/hmg/11.3.229
35. Veldman BA, Spiering W, Doevendans PA et al (2002) The Glu298Asp polymorphism of the NOS 3 gene as a determinant of baseline production of nitric oxide. J Hypertens 20:2023-2027. doi: 10.1097/ 00004872-200210000-00022
36. Nagase S, Suzuki H, Wang Y et al (2003) Association of eNOS gene polymorphisms with end stage renal diseases. Mol Cell Biochem 244:113-118. doi: 10.1023/A:1022473405275
37. Noiri E, Satoh H, Taguchi J et al (2002) Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension 40:535-540. doi: 10.1161/01.HYP.0000033974.57407.82
38. Spoto B, Benedetto FA, Testa A et al (2005) Atherosclerosis and the Glu298Asp polymorphism of the eNOS gene in white patients with end-stage renal disease. Am J Hypertens 18:1549-1555. doi: 10.1016/ j.amjhyper.2005.06.007
39. Zintzaras E, Kitsios G, Stefanidis I (2006) Endothelial NO synthase gene polymorphisms and hypertension: A meta-analysis. Hypertension 48(4):700-710. doi: 10.1161/01.HYP.0000238124.91161.02